{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T14:49:52Z","timestamp":1791557392571,"version":"4.3.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"This study has been partially funded by an ISR grant provided by Jazz Pharmaceuticals (grant #11957)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1038\/s41409-026-02980-4","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T09:36:47Z","timestamp":1784281007000},"page":"1335-1342","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Incidence, clinical risk factors, and biomarkers of SOS\/VOD following allogeneic HSCT in adults. A real-life study by the Spanish group of HSCT and cell therapy (GETH-TC)."],"prefix":"10.1038","volume":"61","author":[{"given":"Ariadna","family":"P\u00e9rez-Mart\u00ednez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7586-4792","authenticated-orcid":false,"given":"M\u00f3nica","family":"Cabrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0024-8068","authenticated-orcid":false,"given":"Juan","family":"Montoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6247-1516","authenticated-orcid":false,"given":"Miriam","family":"S\u00e1nchez-Escamilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda \u00c1ngeles","family":"Cuesta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valle G\u00f3mez-Garc\u00eda","family":"de Soria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6492-1728","authenticated-orcid":false,"given":"Pedro","family":"Gonz\u00e1lez-Sierra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karem","family":"Humala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oriana","family":"L\u00f3pez-Godino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Luna de Abia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1908-5596","authenticated-orcid":false,"given":"Luc\u00eda","family":"L\u00f3pez-Corral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6934-4619","authenticated-orcid":false,"given":"Jaime","family":"Sanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Jes\u00fas","family":"Pascual","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8533-2562","authenticated-orcid":false,"given":"Jos\u00e9 Luis","family":"Pi\u00f1ana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arancha","family":"Berm\u00fadez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Mar\u00eda","family":"Bell\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Filaferro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7889-5807","authenticated-orcid":false,"given":"Guillermo","family":"Orti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascual","family":"Balsalobre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3702-0817","authenticated-orcid":false,"given":"Carlos","family":"Solano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"key":"2980_CR1","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1152\/ajpgi.00526.2002","volume":"284","author":"LD DeLeve","year":"2003","unstructured":"DeLeve LD, Ito Y, Bethea NW, McCuskey MK, Wang X, McCuskey RS. Embolization by sinusoidal lining cells obstructs the microcirculation in rat sinusoidal obstruction syndrome. Am J Physiol Gastrointest Liver Physiol. 2003;284:1045\u201352. https:\/\/doi.org\/10.1152\/ajpgi.00526.2002.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2980_CR2","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.jceh.2014.10.002","volume":"4","author":"CQ Fan","year":"2014","unstructured":"Fan CQ, Crawford JM. Sinusoidal obstruction syndrome (hepatic veno-occlusive disease). J Clin Exp Hepatol. 2014;4:332\u201346. https:\/\/doi.org\/10.1016\/j.jceh.2014.10.002.","journal-title":"J Clin Exp Hepatol"},{"key":"2980_CR3","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1097\/01.HS9.0000848284.17069.95","volume":"6","author":"M Mohty","year":"2022","unstructured":"Mohty M, Yakoub-Agha I, Dalle J, Labopin M. Veno-occlusive disease\/sinusoidal obstruction syndrome after autologous hematopoietic cell transplantation: outcomes of defibrotide-treated adult patients from the DEFIFRANCE study. HemaSphere. 2022;6:1240\u20131. https:\/\/doi.org\/10.1097\/01.HS9.0000848284.17069.95.","journal-title":"HemaSphere"},{"key":"2980_CR4","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/bjh.14727","volume":"178","author":"PG Richardson","year":"2017","unstructured":"Richardson PG, Smith AR, Triplett BM, Kernan NA, Grupp SA, Antin JH, et al. Earlier defibrotide initiation post-diagnosis of veno-occlusive disease\/sinusoidal obstruction syndrome improves Day +100 survival following haematopoietic stem cell transplantation. Br J Haematol. 2017;178:112\u20138. https:\/\/doi.org\/10.1111\/bjh.14727.","journal-title":"Br J Haematol"},{"key":"2980_CR5","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s40261-022-01140-y","volume":"42","author":"S Corbacioglu","year":"2022","unstructured":"Corbacioglu S, Topaloglu O, Aggarwal S. A systematic review and meta-analysis of studies of defibrotide prophylaxis for veno-occlusive disease\/sinusoidal obstruction syndrome. Clin Drug Investig. 2022;42:465\u201376. https:\/\/doi.org\/10.1007\/s40261-022-01140-y.","journal-title":"Clin Drug Investig"},{"key":"2980_CR6","doi-asserted-by":"publisher","first-page":"986.e1","DOI":"10.1016\/j.jtct.2024.07.010","volume":"30","author":"S Putta","year":"2024","unstructured":"Putta S, Young B, Pine P, Shi J, Amber V, Saber W, et al. Verification of the prediction accuracy of a biomarker-based prognostic for Veno-Occlusive Disease\/Sinusoidal Obstruction Syndrome (VOD\/SOS) After Hematopoietic Cell Transplantation (HCT). Transpl Cell Ther. 2024;30:986.e1\u2013986.e7. https:\/\/doi.org\/10.1016\/j.jtct.2024.07.010.","journal-title":"Transpl Cell Ther"},{"key":"2980_CR7","doi-asserted-by":"publisher","first-page":"339","DOI":"10.17219\/ACEM\/115070","volume":"29","author":"Z Szmit","year":"2020","unstructured":"Szmit Z, Gorczy\u0144ska E, Mielcarek-Siedziuk M, Ussowicz M, Owoc-Lempach J, Ka\u0142wak K. Veno-occlusive disease in children and adolescents after hematopoietic stem cell transplantation: did the modified seattle criteria fit the characteristics of pediatric population? Adv Clin Exp Med. 2020;29:339\u201344. https:\/\/doi.org\/10.17219\/ACEM\/115070.","journal-title":"Adv Clin Exp Med"},{"key":"2980_CR8","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1111\/BJH.16557","volume":"190","author":"MS Cairo","year":"2020","unstructured":"Cairo MS, Cooke KR, Lazarus HM, Chao NJ. Modified diagnostic criteria, grading classification and newly elucidated pathophysiology of hepatic SOS\/VOD after haematopoietic cell transplantation. Br J Haematol. 2020;190:822\u201336. https:\/\/doi.org\/10.1111\/BJH.16557.","journal-title":"Br J Haematol"},{"key":"2980_CR9","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41409-024-02434-9","volume":"60","author":"M Larue","year":"2025","unstructured":"Larue M, Labopin M, Brissot E, Alaskar A, Aljurf M, Arat M, et al. An international survey to better understand the current incidence, severity, and management of VOD\/SOS. Bone Marrow Transplant. 2025;60:28\u201331. https:\/\/doi.org\/10.1038\/s41409-024-02434-9.","journal-title":"Bone Marrow Transplant"},{"key":"2980_CR10","doi-asserted-by":"publisher","first-page":"489","DOI":"10.3389\/fimmu.2020.00489","volume":"11","author":"F Bonifazi","year":"2020","unstructured":"Bonifazi F, Barbato F, Ravaioli F, Sessa M, Defrancesco I, Arpinati M, et al. Diagnosis and treatment of VOD\/SOS after allogeneic hematopoietic stem cell transplantation. Front Immunol. 2020;11:489 https:\/\/doi.org\/10.3389\/fimmu.2020.00489. eCollection 2020.","journal-title":"Front Immunol"},{"key":"2980_CR11","doi-asserted-by":"publisher","first-page":"96","DOI":"10.7889\/tct-24-002","volume":"13","author":"K Yakushihin","year":"2024","unstructured":"Yakushihin K, Nishida M. The diagnosis of Sinusoidal Obstruction Syndrome\/Veno-Occlusive Disease Using Ultrasonography. Jpn J Transplant. 2024;13:96\u2013103. https:\/\/doi.org\/10.7889\/tct-24-002.","journal-title":"Jpn J Transplant"},{"key":"2980_CR12","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1038\/bmt.2016.130","volume":"51","author":"M Mohty","year":"2016","unstructured":"Mohty M, Malard F, Abecassis M, Aerts E, Alaskar AS, Aljurf M, et al. Revised diagnosis and severity criteria for sinusoidal obstruction syndrome\/veno-occlusive disease in adult patients: a new classification from the European Society for blood and Marrow Transplantation. Bone Marrow Transplant. 2016;51:906\u201312. https:\/\/doi.org\/10.1038\/bmt.2016.130.","journal-title":"Bone Marrow Transplant"},{"key":"2980_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41409-023-01992-8","volume":"58","author":"M Mohty","year":"2023","unstructured":"Mohty M, Malard F, Alaskar A, Aljurf M, Arat M, Bader P, et al. Diagnosis and severity criteria for sinusoidal obstruction syndrome\/veno-occlusive disease in adult patients: a refined classification from the European Society for Blood and Marrow Transplantation (EBMT). Bone Marrow Transpl. 2023;58:1\u20136. https:\/\/doi.org\/10.1038\/s41409-023-01992-8.","journal-title":"Bone Marrow Transpl"},{"key":"2980_CR14","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.bbmt.2020.01.028","volume":"26","author":"A Varma","year":"2020","unstructured":"Varma A, Rondon G, Srour SA, Chen J, Ledesma C, Champlin RE, et al. Endothelial Activation and Stress Index (EASIX) at admission predicts fluid overload in recipients of allogeneic stem cell transplantation. Biol Blood Marrow Transplant. 2020;26:1013\u201320. https:\/\/doi.org\/10.1016\/j.bbmt.2020.01.028.","journal-title":"Biol Blood Marrow Transplant"},{"key":"2980_CR15","doi-asserted-by":"publisher","first-page":"446","DOI":"10.3324\/haematol.2019.238790","volume":"106","author":"S Jiang","year":"2021","unstructured":"Jiang S, Penack O, Terzer T, Schult D, Majer-Lauterbach J, Radujkovic A, et al. Predicting sinusoidal obstruction syndrome after allogeneic stem cell transplantation with the EASIX biomarker panel. Haematologica. 2021;106:446\u201353. https:\/\/doi.org\/10.3324\/haematol.2019.238790.","journal-title":"Haematologica"},{"key":"2980_CR16","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/s41409-024-02489-8","volume":"60","author":"E Muratore","year":"2025","unstructured":"Muratore E, Gambuti G, Leardini D, Baccelli F, Venturelli F, Larcinese L, et al. The EASIX score as a predictor of sinusoidal obstruction syndrome and nonrelapse mortality in paediatric patients receiving allogeneic haematopoietic stem cell transplantation. Bone Marrow Transplant. 2025;60:346\u201352. https:\/\/doi.org\/10.1038\/s41409-024-02489-8.","journal-title":"Bone Marrow Transplant"},{"key":"2980_CR17","doi-asserted-by":"publisher","first-page":"e414","DOI":"10.1016\/S2352-3026(17)30108-4","volume":"4","author":"T Luft","year":"2017","unstructured":"Luft T, Benner A, Jodele S, Dandoy CE, Storb R, Gooley T, et al. EASIX in patients with acute graft-versus-host disease: a retrospective cohort analysis. Lancet Haematol. 2017;4:e414\u2013e423. https:\/\/doi.org\/10.1016\/S2352-3026(17)30108-4.","journal-title":"Lancet Haematol"},{"key":"2980_CR18","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1016\/j.bbmt.2009.07.004","volume":"15","author":"A Bacigalupo","year":"2009","unstructured":"Bacigalupo A, Ballen K, Rizzo D, Giralt S, Lazarus HM, Ho V, et al. Defining the intensity of conditioning regimens: working definitions. Biol Blood Marrow Transpl. 2009;15:1628\u201333.","journal-title":"Biol Blood Marrow Transpl"},{"key":"2980_CR19","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.bbmt.2015.09.024","volume":"22","author":"JH Dalle","year":"2016","unstructured":"Dalle JH, Giralt SA. Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: risk factors and stratification, prophylaxis, and treatment. Biol Blood Marrow Transplant. 2016;22:400\u20139. https:\/\/doi.org\/10.1016\/j.bbmt.2015.09.024.","journal-title":"Biol Blood Marrow Transplant"},{"key":"2980_CR20","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1038\/s41409-023-02077-2","volume":"58","author":"T Ruutu","year":"2023","unstructured":"Ruutu T, Peczynski C, Houhou M, Polge E, Mohty M, Kr\u00f6ger N, et al. Current incidence, severity, and management of veno-occlusive disease\/sinusoidal obstruction syndrome in adult allogeneic HSCT recipients: an EBMT transplant complications working party study. Bone Marrow Transplant. 2023;58:1209\u201314. https:\/\/doi.org\/10.1038\/s41409-023-02077-2.","journal-title":"Bone Marrow Transplant"},{"key":"2980_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-022-09915-4","volume":"22","author":"S Park","year":"2022","unstructured":"Park S, Go SI, Lee GW. The Endothelial Activation and Stress Index (EASIX) score is an independent prognostic factor in patients with diffuse large B-cell lymphoma. BMC Cancer. 2022;22:816. https:\/\/doi.org\/10.1186\/s12885-022-09915-4.","journal-title":"BMC Cancer"},{"key":"2980_CR22","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.3390\/jcm12072553","volume":"12","author":"D Schult","year":"2023","unstructured":"Schult D, Rasch S, Schmid RM, Lahmer T, Mayr U. EASIX is an accurate and easily available prognostic score in critically Ill patients with advanced liver disease. J Clin Med. 2023;12:2553 https:\/\/doi.org\/10.3390\/jcm12072553.","journal-title":"J Clin Med"},{"key":"2980_CR23","doi-asserted-by":"publisher","first-page":"187.e1","DOI":"10.1016\/j.jtct.2023.11.016","volume":"30","author":"A Pedraza","year":"2024","unstructured":"Pedraza A, Salas MQ, Rodr\u00edguez-Lobato LG, Escribano-Serrat S, Suarez-Lledo M, Martinez-Cebria N, et al. Easix score correlates with endothelial dysfunction biomarkers and predicts risk of acute graft-versus-host disease after allogeneic transplantation. Transpl Cell Ther. 2024;30:187.e1\u2013187.e12. https:\/\/doi.org\/10.1016\/j.jtct.2023.11.016.","journal-title":"Transpl Cell Ther"},{"key":"2980_CR24","doi-asserted-by":"publisher","first-page":"4520","DOI":"10.1182\/blood-2019-125332","volume":"134","author":"E Gavriilaki","year":"2019","unstructured":"Gavriilaki E, Sakellari I, Chatziconstantinou T, Mallouri D, Batsis I, Vardi A, et al. Easix is strongly associated with complement activation and overall survival in adult allogeneic hematopoietic cell transplantation recipients. Blood. 2019;134:4520 https:\/\/doi.org\/10.1182\/blood-2019-125332.","journal-title":"Blood"},{"key":"2980_CR25","doi-asserted-by":"publisher","first-page":"5620","DOI":"10.3390\/ijms24065620","volume":"24","author":"I Mavrikou","year":"2023","unstructured":"Mavrikou I, Chatzidimitriou D, Skoura L, Nikolousis E, Sakellari I, Gavriilaki E. Molecular advances in sinusoidal obstruction syndrome\/veno-occlusive disease. Int J Mol Sci. 2023;24:5620 https:\/\/doi.org\/10.3390\/ijms24065620.","journal-title":"Int J Mol Sci"},{"key":"2980_CR26","doi-asserted-by":"publisher","unstructured":"Wang Y, Dong F, Sun S, Wang X, Zheng X, Huang Y, et al. Increased INR values predict accelerating deterioration and high short-term mortality among patients hospitalized with cirrhosis or advanced fibrosis. Front Med China 2021; 8. https:\/\/doi.org\/10.3389\/FMED.2021.762291","DOI":"10.3389\/FMED.2021.762291"},{"key":"2980_CR27","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.bbmt.2018.07.039","volume":"25","author":"LE Roeker","year":"2019","unstructured":"Roeker LE, Kim HT, Glotzbecker B, Nageshwar P, Nikiforow S, Koreth J, et al. Early clinical predictors of hepatic veno-occlusive disease\/sinusoidal obstruction syndrome after myeloablative stem cell transplantation. Biol Blood Marrow Transplant. 2019;25:137\u201344. https:\/\/doi.org\/10.1016\/j.bbmt.2018.07.039.","journal-title":"Biol Blood Marrow Transplant"},{"key":"2980_CR28","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s00432-023-05561-w","volume":"150","author":"L Johann","year":"2024","unstructured":"Johann L, Gruhn B. Analysis of laboratory parameters before the occurrence of hepatic sinusoidal obstruction syndrome in children, adolescents, and young adults after hematopoietic stem cell transplantation. J Cancer Res Clin Oncol. 2024;150:9 https:\/\/doi.org\/10.1007\/s00432-023-05561-w.","journal-title":"J Cancer Res Clin Oncol"},{"key":"2980_CR29","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41409-018-0233-2","volume":"54","author":"F Khimani","year":"2019","unstructured":"Khimani F, McDonald GB, Shulman HM, Betts B, Locke F, Fernandez H, et al. Hepatic veno-occlusive disease following sirolimus-based immune suppression. Bone Marrow Transplant. 2019;54:85\u201389. https:\/\/doi.org\/10.1038\/s41409-018-0233-2.","journal-title":"Bone Marrow Transplant"},{"key":"2980_CR30","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/s41409-020-0987-1","volume":"56","author":"V Agrawal","year":"2021","unstructured":"Agrawal V, Ranganath P, Ervin KD, Schmidt C, Cox EA, Nelson RP, et al. Effect of Sirolimus levels between days 11 and 20 after allogeneic stem cell transplantation on the risk of hepatic sinusoidal obstruction syndrome. Bone Marrow Transplant. 2021;56:121\u20138. https:\/\/doi.org\/10.1038\/s41409-020-0987-1.","journal-title":"Bone Marrow Transplant"},{"key":"2980_CR31","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1182\/bloodadvances.2023011233","volume":"8","author":"C Marcoux","year":"2024","unstructured":"Marcoux C, Saliba RM, Wallis W, Khazal S, Ragoonanan D, Rondon G, et al. Incidence and risk factors of early onset VOD\/SOS differ in younger vs older adults after stem cell transplantation. Blood Adv. 2024;8:1128\u201336. https:\/\/doi.org\/10.1182\/bloodadvances.2023011233.","journal-title":"Blood Adv"},{"key":"2980_CR32","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.bbmt.2009.08.024","volume":"16","author":"JA Coppell","year":"2010","unstructured":"Coppell JA, Richardson PG, Soiffer R, Martin PL, Kernan NA, Chen A, et al. Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome. Biol Blood Marrow Transplant. 2010;16:157\u201368.","journal-title":"Biol Blood Marrow Transplant"},{"key":"2980_CR33","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/s41409-020-01135-3","volume":"56","author":"AH Bazarbachi","year":"2021","unstructured":"Bazarbachi AH, Al Hamed R, Labopin M, Halaburda K, Labussiere H, Bernasconi P, et al. Underdiagnosed veno-occlusive disease\/sinusoidal obstruction syndrome (VOD\/SOS) as a major cause of multi-organ failure in acute leukemia transplant patients: an analysis from the EBMT Acute Leukemia Working Party. Bone Marrow Transplant. 2021;56:917\u201327.","journal-title":"Bone Marrow Transplant"},{"key":"2980_CR34","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.critrevonc.2018.05.017","volume":"133","author":"X Yu","year":"2019","unstructured":"Yu X, Liu L, Xie Z, Dong C, Zhao L, Zhang J, et al. Bone marrow versus peripheral blood as a graft source for haploidentical donor transplantation in adults using post-transplant Cyclophosphamide-A systematic review and meta-analysis. Crit Rev Oncol Hemat. 2019;133:120\u20138.","journal-title":"Crit Rev Oncol Hemat"},{"key":"2980_CR35","first-page":"674.e1","volume":"31","author":"A Balaguer-Rosell\u00f3","year":"2025","unstructured":"Balaguer-Rosell\u00f3 A, Montoro J, Villalba M, Lizama P, Torres L, Chor\u00e3o P, et al. Sinusoidal obstruction syndrome after allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide. Transpl Cell Ther. 2025;31:674.e1\u2013674.e13.","journal-title":"Transpl Cell Ther"},{"key":"2980_CR36","first-page":"914.e1","volume":"30","author":"I G\u00f3mez-Centuri\u00f3n","year":"2024","unstructured":"G\u00f3mez-Centuri\u00f3n I, Gallardo Morillo AI, P\u00e9rez Mart\u00ednez A, Cabrero Calvo M, Chinea A, Gonz\u00e1lez L, et al. Sinusoidal obstruction syndrome\/veno-occlusive disease after unmanipulated haploidentical hematopoietic stem cell transplantation with post-transplantation cyclophosphamide: a study on behalf of the Spanish Hematopoietic Stem Cell Transplantation and Cellular Therapy Group (GETH). Transpl Cell Ther. 2024;30:914.e1\u2013914.e8.","journal-title":"Transpl Cell Ther"},{"key":"2980_CR37","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1111\/ajt.16345","volume":"21","author":"V Mehra","year":"2021","unstructured":"Mehra V, Tetlow S, Choy A, de Lavallade H, Kulasekararaj A, Krishnamurthy P, et al. Early and late-onset veno-occlusive disease\/sinusoidal syndrome post allogeneic stem cell transplantation - a real-world UK experience. Am J Transplant. 2021;21:864\u20139.","journal-title":"Am J Transplant"},{"key":"2980_CR38","doi-asserted-by":"publisher","first-page":"580.e1","DOI":"10.1016\/j.jtct.2024.03.026","volume":"30","author":"M Farina","year":"2024","unstructured":"Farina M, Scaini MC, Facchinetti A, Leoni A, Bernardi S, Catoni C, et al. Evaluation of circulating endothelial cells as direct marker of endothelial damage in allo-transplant recipients at high risk of hepatic veno-occlusive disease\/sinusoidal obstruction syndrome. Transpl Cell Ther. 2024;30:580.e1\u2013580.e14. https:\/\/doi.org\/10.1016\/j.jtct.2024.03.026.","journal-title":"Transpl Cell Ther"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41409-026-02980-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-026-02980-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-026-02980-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T13:59:35Z","timestamp":1791554375000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-026-02980-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":38,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["2980"],"URL":"https:\/\/doi.org\/10.1038\/s41409-026-02980-4","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,17]]},"assertion":[{"value":"2 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study has been partially funded by an ISR grant provided by Jazz Pharmaceuticals (grant #11957). Guillermo Orti, MD, PhD., has received honoraria from Chiesi, Jazz, MSD, Novartis, Orca Bio, Pfizer, Sanofi and Therakos. Travel support from Incyte, Jazz, Novartis, Pfizer and Sanofi. He has received research support from Incyte (institutional). Carlos Solano has received honoraria from MSD, Jazz, Novartis, Pfizer, Sanofi and Therakos; travel support from Gilead, Jazz, Novartis, Pfizer and Sanofi. The other authors have no conflict of interest regarding this publication.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The local research ethics committee of the Hospital Cl\u00ednico Universitario of Valencia approved the registry and study protocol (reference code 175\/22).","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The local ethics committee permits the waiver of signed informed consent, given its retrospective observational nature.","order":3,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Ethics"}}]}}